Clinical Trial Update: Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotic [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating a probiotic to reduce HPV abundance in women (Phase 2/3) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Probiotic supplement

Snippet

Sponsor: Universiti Sains Malaysia | Conditions: Human Papilloma Virus Infection | Phase 2, Phase 3 | Status: WITHDRAWN